Tracked deals
80
80 tracked deals across 2016-2026.
Washington, District of Columbia, United States
Washington, D.C.-area private investment firm specializing in government-regulated industries. Arlington partners with founders and management teams to build strategically important businesses in aerospace and defense, government services and technology, and healthcare.
Tracked deals
80
80 tracked deals across 2016-2026.
Recent pace
9
9 tracked deals announced in the last 12 months.
Deal mix
Addon
49 addon · 28 buyout · 1 divestiture
Last 9 years
Supporting Data
Showing the 12 most recent of 80 tracked deals for Arlington Capital Partners.
AVS Bio, a portfolio company of Arlington Capital Partners, announced it has acquired Biorbyt Ltd., a global supplier of bio-reagents and related biomaterials for life science research. The acquisition is intended to expand AVS Bio’s biomaterials catalog and add Biorbyt’s advanced ecommerce platform to improve global distribution capabilities.
Everest Clinical Research (“Everest”) announced the acquisition of the Biometrics and Data Services business unit of Firma Clinical Research (“Firma DS”). The deal expands Everest’s global biometrics expertise and clinical data science capabilities, adding an experienced biometrics team and supporting clients across the clinical development lifecycle.
TRP Infrastructure Services, a pavement marking and traffic control contractor, completed the acquisition of five roadway infrastructure companies to expand its operations across the Central and Southeastern United States. The portfolio company also launched Gulf Highway Materials, adding a thermoplastic pavement markings manufacturing division to vertically integrate part of its materials supply chain.
Novanta has completed its acquisition of Riverpoint Medical from Arlington Capital Partners for an upfront cash consideration of $1.2 billion plus a $250 million milestone payment. The deal expands Novanta’s portfolio into high-growth minimally invasive surgical consumables and is expected to double Novanta’s recurring medical consumables revenue to roughly $300 million.
Arlington Capital Partners acquired ENERCON, a specialized nuclear and highly regulated power engineering firm, from funds managed by Oaktree. As part of the transaction, ENERCON will merge with Arlington portfolio company Pond & Company and operate under the ENERCON name from Atlanta-area headquarters.
Arlington Capital Partners entered into an agreement to acquire Eptec Defence, a Sydney-headquartered naval remediation and preservation services provider supporting the Royal Australian Navy and allied fleets. The deal is subject to customary closing conditions and regulatory approvals, and Arlington plans to appoint Steve Zogas as CEO while keeping Eptec Defence’s existing management team in place operationally.
TRP Infrastructure Services, a Fort Worth-based pavement marking and traffic control platform backed by Arlington Capital Partners, has acquired Striping Technology, L.P., a Tyler, Texas pavement marking contractor. Striping Technology will operate as TRP's East Texas division to deepen the company's presence in Texas and accelerate TRP's expansion across the Southeast; financial terms were not disclosed.
Arlington Capital Partners has acquired Pond & Company, a full-service design and engineering firm that supports federal government and private clients across energy, infrastructure and life sciences. The deal is Arlington's first platform investment from its oversubscribed $6 billion Fund VII; Pond is headquartered in Peachtree Corners, Georgia and employs more than 850 professionals across 21 offices. DC Capital Partners, which held a majority stake since 2019, sold the business.
TRP Infrastructure Services, a portfolio company of Arlington Capital Partners, has acquired Highway Barricades & Services, LLC. The Corpus Christi-based pavement marking and traffic control firm will operate as TRP's South Texas division, expanding TRP's regional footprint and capabilities to better serve government customers such as the Texas Department of Transportation.
Systems Planning & Analysis (SPA), a portfolio company of Arlington Capital Partners, has acquired Group W, a Vienna, Virginia–based data science and defense analytics firm focused on modeling, simulation, and wargaming for the Department of Defense. The deal expands SPA's mission-critical modeling and simulation capabilities across system, mission, and campaign levels and integrates Group W's advanced analytical and wargaming expertise into SPA's national security offerings.
Arlington Capital Partners completed a majority growth investment in Concord Biomedical Sciences and Emerging Technologies, Inc. (CBSET), a Boston-area provider of translational research and product development services for the medical device and life sciences markets. The investment is intended to help CBSET scale its integrated preclinical research and testing platform via capacity expansion and strategic add-on acquisitions.
TEAM Technologies, a portfolio company of Arlington Capital Partners, has acquired TAG3 Engineering LLC, a MedTech design, development, and manufacturing firm based in Sunrise, Florida. The add-on expands TEAM Tech's front-end design, regulatory/V&V, and product innovation capabilities to accelerate speed-to-market across cardiovascular, neurovascular and other minimally invasive device markets.
Turn tracked acquisition activity into an outreach-ready buyer list.